Combination therapy protects against advanced Marburg virus disease

(University of Texas Medical Branch at Galveston) A new study conducted at the Galveston National Laboratory at the The University of Texas Medical Branch at Galveston (UTMB) has shown substantial benefit to combining monoclonal antibodies and the antiviral remdesivir against advanced Marburg virus. The study was published today in Nature Communications.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news